Response of plasma glicentin to fat ingestion in piglets, Diabetes Research and Clinical Practice, vol.3, issue.2, pp.103-112, 1987. ,
DOI : 10.1016/S0168-8227(87)80014-1
Postnatal and postprandial changes in plasma concentrations of glicentin in term and preterm infants, Acta Paediatrica, vol.1, issue.10, pp.1175-1184, 2003. ,
DOI : 10.1111/j.1651-2227.2003.tb02480.x
Effects of extremely early enteral feeding on plasma glicentin levels in very-low-birthweight infants, Journal of Paediatrics and Child Health, vol.17, issue.10, pp.636-645, 2006. ,
DOI : 10.1097/00075197-200111000-00015
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine., Journal of Clinical Investigation, vol.87, issue.2, pp.415-438, 1991. ,
DOI : 10.1172/JCI115012
Plasma glicentin in diabetic and gastrectomized patients, Regulatory Peptides, vol.79, issue.1, pp.55-61, 1999. ,
DOI : 10.1016/S0167-0115(98)00144-X
Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986. ,
DOI : 10.1007/BF00903352
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis, The American Journal of Medicine, vol.122, issue.3, pp.248-56, 2009. ,
DOI : 10.1016/j.amjmed.2008.09.041
TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, Circulation, vol.129, issue.25 2, pp.102-140, 2014. ,
Metabolic/Bariatric Surgery Worldwide 2008, Obesity Surgery, vol.196, issue.12, pp.1605-1616, 2008. ,
DOI : 10.1007/s11695-009-0014-5
How to Choose and Use Bariatric Surgery in 2015, Canadian Journal of Cardiology, vol.31, issue.2, pp.153-66, 2015. ,
DOI : 10.1016/j.cjca.2014.12.014
Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery, Current Opinion in Pharmacology, vol.13, issue.6, pp.983-991, 2013. ,
DOI : 10.1016/j.coph.2013.09.014
Influence of diabetes surgery on gut hormones and incretins, Nutr Hosp, vol.28, issue.2, pp.95-103, 2013. ,
Gastrointestinal hormones and bariatric surgery-induced weight loss, Obesity, vol.244, issue.2 Suppl, pp.1093-103, 2013. ,
DOI : 10.1002/oby.20364
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423817
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass, Diabetologia, vol.46, issue.Suppl. 1, pp.1890-901, 2012. ,
DOI : 10.1007/s00125-012-2556-7
Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-57, 2007. ,
DOI : 10.1053/j.gastro.2007.03.054
ENTEROGLUCAGON, Annual Review of Physiology, vol.59, issue.1, pp.257-71, 1997. ,
DOI : 10.1146/annurev.physiol.59.1.257
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery, ISRN Endocrinology, vol.4, issue.1 ,
DOI : 10.1007/s00464-008-0069-8
Relationship between gut hormones and glucose homeostasis after bariatric surgery, Diabetology & Metabolic Syndrome, vol.6, issue.1, p.87, 2014. ,
DOI : 10.1186/1758-5996-6-87
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141947
Glicentin inhibits gastric acid secretion in the rat, Nature, vol.14, issue.5862, pp.156-163, 1982. ,
DOI : 10.1038/297156a0
Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro, Journal of Gastroenterology, vol.3, issue.Suppl 2, pp.300-305, 1997. ,
DOI : 10.1007/BF02934484
Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine, Neurogastroenterology and Motility, vol.67, issue.4, pp.455-63, 2004. ,
DOI : 10.1210/en.140.1.22
Role of recombinant human glicentin in the normal human jejunum: an in vitro study, Hepatogastroenterology, vol.52, issue.65, pp.1459-62, 2005. ,
Insulinotropic action of human glicentin in dogs, Metabolism, vol.44, issue.1, pp.47-51, 1995. ,
DOI : 10.1016/0026-0495(95)90288-0
Plasma glicentin in diabetic and gastrectomized patients, Regulatory Peptides, vol.79, issue.1, pp.55-61, 1999. ,
DOI : 10.1016/S0167-0115(98)00144-X
The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs, BMC Research Notes, vol.91, issue.1, p.60, 2016. ,
DOI : 10.1186/s13104-016-1872-2
Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes, Endocrinology, vol.140, issue.1, pp.22-30, 1999. ,
Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39), Neurogastroenterology and Motility, vol.55, issue.2, pp.302-311, 2005. ,
DOI : 10.1210/jc.2004-0189
URL : https://hal.archives-ouvertes.fr/hal-00358720
Gastrointestinal changes after bariatric surgery, Diabetes & Metabolism, vol.40, issue.2, pp.87-94, 2014. ,
DOI : 10.1016/j.diabet.2013.11.003
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes, Diabetologia, vol.3, issue.10, pp.2254-2262, 2015. ,
DOI : 10.1007/s00125-015-3696-3
Changes in Lipid Profiles in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy (LSG), Obesity Surgery, vol.238, issue.12, pp.305-314, 2011. ,
DOI : 10.1007/s11695-010-0285-x
Impact of Roux-en-Y gastric bypass on lipid and inflammatory profiles, Revista do Col??gio Brasileiro de Cirurgi??es, vol.42, issue.5, pp.305-315, 2015. ,
DOI : 10.1590/0100-69912015005007
Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas., The Tohoku Journal of Experimental Medicine, vol.155, issue.2, pp.197-204, 1988. ,
DOI : 10.1620/tjem.155.197
Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986. ,
DOI : 10.1007/BF00903352
Long-term mortality after gastric bypass surgery, N Engl J Med, vol.357, issue.8, pp.753-761, 2007. ,
Glucagon receptors, Cellular and Molecular Life Sciences, vol.65, issue.12, pp.1880-99, 2008. ,
DOI : 10.1007/s00018-008-7479-6
URL : https://hal.archives-ouvertes.fr/inserm-00289267
Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-2157, 2007. ,
DOI : 10.1053/j.gastro.2007.03.054
Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology, Journal of Molecular Medicine, vol.127, issue.Endocrinol Meta, pp.673-684, 2007. ,
DOI : 10.1007/s00109-007-0167-4
URL : https://hal.archives-ouvertes.fr/hal-00175786
The forgotten members of the glucagon family, Diabetes Research and Clinical Practice, vol.106, issue.1, pp.1-10, 2014. ,
DOI : 10.1016/j.diabres.2014.06.010
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis, The American Journal of Medicine, vol.122, issue.3, pp.248-256, 2009. ,
DOI : 10.1016/j.amjmed.2008.09.041
The gut???brain axis in obesity, Best Practice & Research Clinical Gastroenterology, vol.28, issue.4, pp.559-571, 2014. ,
DOI : 10.1016/j.bpg.2014.07.003
Glucagon-like peptide 2: a nutrientresponsive gut growth factor, J Nutr, vol.131, issue.3, pp.709-721, 2001. ,
The Global Epidemic of Obesity: An Overview, Epidemiologic Reviews, vol.29, issue.1, pp.1-5, 2007. ,
DOI : 10.1093/epirev/mxm012
[From bariatric to metabolic surgery: 15 years experience in a French university hospital], Bull Acad Natl Med, vol.194, issue.1, pp.25-36, 2010. ,
Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes, Pediatric Surgery International, vol.24, issue.6, pp.551-554, 2007. ,
DOI : 10.1007/s00383-007-1895-9
Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity, Surgical Endoscopy, vol.183, issue.6, pp.859-863, 2006. ,
DOI : 10.1007/s00464-005-0134-5
Evolution of Obesity Prevalence in France, Epidemiology, vol.21, issue.3, pp.360-365, 2010. ,
DOI : 10.1097/EDE.0b013e3181d5bff5
URL : https://hal.archives-ouvertes.fr/inserm-00559257
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass, Diabetologia, vol.46, issue.Suppl. 1, pp.1890-1901, 2012. ,
DOI : 10.1007/s00125-012-2556-7
Prader???Willi syndrome: From genetics to behaviour, with special focus on appetite treatments, Neuroscience & Biobehavioral Reviews, vol.59, pp.155-172, 2015. ,
DOI : 10.1016/j.neubiorev.2015.10.003
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery, ISRN Endocrinology, vol.4, issue.1, p.504756, 2012. ,
DOI : 10.1007/s00464-008-0069-8
Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-vella fistulas, Journal of Pediatric Surgery, vol.38, issue.4, pp.579-584, 2003. ,
DOI : 10.1053/jpsu.2003.50126
ENTEROGLUCAGON, Annual Review of Physiology, vol.59, issue.1, pp.257-271, 1997. ,
DOI : 10.1146/annurev.physiol.59.1.257
Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery, Current Opinion in Pharmacology, vol.13, issue.6, pp.983-988, 2013. ,
DOI : 10.1016/j.coph.2013.09.014
Effects of Fasting, Refeeding, and Intraluminal Triglyceride on Proglucagon Expression in Jejunum and Ileum, Diabetes, vol.45, issue.4, pp.434-439, 1996. ,
DOI : 10.2337/diab.45.4.434
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects, European Journal of Endocrinology, vol.146, issue.6, pp.863-872, 2002. ,
DOI : 10.1530/eje.0.1460863
Gastrointestinal hormones and bariatric surgery-induced weight loss, Obesity, vol.244, issue.2 Suppl, pp.1093-1103, 2013. ,
DOI : 10.1002/oby.20364
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423817
Enteroendocrine hormone mimetics for the treatment of obesity and diabetes, Current Opinion in Pharmacology, vol.13, issue.6, pp.989-995, 2013. ,
DOI : 10.1016/j.coph.2013.09.009
American College of Cardiology/American Heart Association Task Force on Practice and S2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, Obesity J Am Coll Cardiol, vol.6325, pp.2985-3023, 2014. ,
Obesity as a medical problem, Nature, vol.404, issue.6778, pp.635-643, 2000. ,
Obesity in youth and middle age and risk of colorectal cancer in men, Cancer Causes & Control, vol.128, issue.4, pp.349-354, 1992. ,
DOI : 10.1007/BF00146888
Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results, Surgical Endoscopy, vol.106, issue.7, pp.1810-1816, 2007. ,
DOI : 10.1007/s00464-007-9276-y
New frontiers in the biology of GLP-2, Regulatory Peptides, vol.90, issue.1-3, pp.1-327, 2000. ,
DOI : 10.1016/S0167-0115(00)00117-8
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.3, pp.1181-1189, 2016. ,
DOI : 10.1210/jc.2015-3885
Obesity and lung function: a systematic review, Einstein (S??o Paulo), vol.12, issue.1, pp.120-125, 2014. ,
DOI : 10.1590/S1679-45082014RW2691
Obesity, interrelated mechanisms, and exposures and kidney cancer, Semin Urol Oncol, vol.19, issue.4, pp.270-279, 2001. ,
Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999-2006, Diabetes Care, vol.34, issue.1, pp.216-219, 2011. ,
DOI : 10.2337/dc10-0879
Gut hormones and the regulation of energy homeostasis, Nature, vol.243, issue.7121, pp.854-859, 2006. ,
DOI : 10.1038/nature05484
Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro, Journal of Gastroenterology, vol.3, issue.Suppl 2, pp.300-305, 1997. ,
DOI : 10.1007/BF02934484
Plasma glicentin in diabetic and gastrectomized patients, Regul Pept, vol.79, issue.1, pp.55-61, 1999. ,
Response of plasma glicentin to intraduodenal administration of glucose in piglets, Diabetes Research and Clinical Practice, vol.3, issue.2, pp.97-102, 1987. ,
DOI : 10.1016/S0168-8227(87)80013-X
Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986. ,
DOI : 10.1007/BF00903352
Effect of intraluminal administration of amino acids upon plasma glicentin, Diabetes Research and Clinical Practice, vol.5, issue.4, pp.265-270, 1988. ,
DOI : 10.1016/S0168-8227(88)80061-5
Insulinotropic action of human glicentin in dogs, Metabolism, vol.44, issue.1, pp.47-51, 1995. ,
DOI : 10.1016/0026-0495(95)90288-0
Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas., The Tohoku Journal of Experimental Medicine, vol.155, issue.2, pp.197-204, 1988. ,
DOI : 10.1620/tjem.155.197
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine., Journal of Clinical Investigation, vol.87, issue.2, pp.415-423, 1991. ,
DOI : 10.1172/JCI115012
Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period, European Journal of Endocrinology, vol.160, issue.1, pp.53-61, 2009. ,
DOI : 10.1530/EJE-08-0807
Influence of diabetes surgery on gut hormones and incretins, Nutr Hosp, vol.28, issue.2, pp.95-103, 2013. ,
Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine, Neurogastroenterology and Motility, vol.67, issue.4, pp.455-463, 2004. ,
DOI : 10.1210/en.140.1.22
How to Choose and Use Bariatric Surgery in 2015, Canadian Journal of Cardiology, vol.31, issue.2, pp.153-166, 2015. ,
DOI : 10.1016/j.cjca.2014.12.014
Unraveling oxyntomodulin, GLP1's enigmatic brother, Journal of Endocrinology, vol.215, issue.3, pp.335-381, 2012. ,
DOI : 10.1530/JOE-12-0368
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493657
Prognostic value of obesity on both overall mortality and cardiovascular disease in the general population, Vascular Diseases from PLoS One, vol.10, issue.5, p.127369, 2015. ,
The nutrition transition: worldwide obesity dynamics and their determinants, International Journal of Obesity, vol.28, issue.3, pp.2-9, 2004. ,
DOI : 10.1038/sj.ijo.0802804
Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus, Annals of Surgery, vol.222, issue.3, pp.339-350, 1995. ,
DOI : 10.1097/00000658-199509000-00011
The metabolic syndrome: the future is now, Acta Physiologica, vol.372, issue.Suppl 1, pp.291-294, 2015. ,
DOI : 10.1111/apha.12530
Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes, Endocrinology, vol.140, issue.1, pp.22-28, 1999. ,
Relationship between gut hormones and glucose homeostasis after bariatric surgery, Diabetology & Metabolic Syndrome, vol.6, issue.1, p.87, 2014. ,
DOI : 10.1186/1758-5996-6-87
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141947
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease, Physiological Reviews, vol.95, issue.2, pp.513-548, 2015. ,
DOI : 10.1152/physrev.00013.2014
Gastric secretion, Current Opinion in Gastroenterology, vol.30, issue.6, pp.578-82, 2014. ,
DOI : 10.1097/MOG.0000000000000125
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential, Physiology, vol.20, issue.5, pp.357-365, 2005. ,
DOI : 10.1152/physiol.00030.2005
Upper abdominal obesity, insulin resistance and breast cancer risk, Int J Obes Relat Metab Disord, vol.26, issue.6, pp.747-753, 2002. ,
Gut hormones as therapeutic agents in treatment of diabetes and obesity, Current Opinion in Pharmacology, vol.13, issue.6, pp.996-1001, 2013. ,
DOI : 10.1016/j.coph.2013.09.005
Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.675, issue.2, pp.163-170, 1981. ,
DOI : 10.1016/0304-4165(81)90222-1
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1., Proceedings of the National Academy of Sciences, vol.89, issue.18, pp.8641-8646, 1992. ,
DOI : 10.1073/pnas.89.18.8641
Role of recombinant human glicentin in the normal human jejunum: an in vitro study, Hepatogastroenterology, vol.52, issue.65, pp.1459-1462, 2005. ,